Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
aPRP in Retinitis Pigmentosa
NCT04238858Completed
- Sponsor
- Ankara Üniversitesi Teknokent
- Start
- Sep 2016
- Primary completion
- Feb 2017
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Open-label trial of platelet-rich plasma in retinitis pigmentosa (RP) (2 arms), sponsored by Ankara Üniversitesi Teknokent. Primary endpoint: Visual field sensitivity at 1 month. Started Sep 2016; status: completed.
02
Drugs
platelet-rich plasma
03
Conditions
retinitis pigmentosa (RP)
Beyond the preview
Go deeper on NCT04238858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04238858.